The decree relating to “advanced therapy medicinal products” was published in the Journal Officiel on 8 November. A decree awaited since the adoption of the Law of 22 March 2011 allowing organizations to become non-profit pharmaceutical establishments. In the coming days, Genethon submit its application for accreditation by the National Security Agency of the drug (MSNA).
With this decree, Genethon will be able to accelerate the production of gene therapy for human trials through its center, Genethon Bioprod, which has the largest capacity in the world in this field.
Read the press release – 08/11/2012 (FRENCH – 1 page – 141 ko)
